Results
1 -
10 of
10
(Click
here to explore results)
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 4 Small-molecule and Synthetically Derived Antivirals for Ebola Virus and Other Filoviruses. Patrick Iversen, Sandra Bixler, Christopher D. Kane, Travis K. Warren
, 2022
, Pages 61-90
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 4 Discovery and Development of Antiviral Drugs for Treatment of Pathogenic Human Orthopoxvirus Infections. Robert Jordan
, 2013
, Pages 81-110
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Subject Index
, 2022
, Pages 280-290
- Aerobiology: The Toxicology of Airborne Pathogens and Toxins, CHAPTER 2 Orthopoxviruses and Animal Models for Pathogenesis, Vaccine and Drug Studies. M. Sofi Ibrahim, Hermann Meyer
, 2016
, Pages 42-71
- Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
- Successful Strategies for the Discovery of Antiviral Drugs, Contents
, 2013
, Pages P009-P016
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Carbon Nanostructures for Biomedical Applications, CHAPTER 3 Multivalent Glycosylated Carbon Nanostructures: Efficient Inhibitors of Emergent Viruses Infection. Javier Ramos-Soriano, Alfonso Pérez-Sánchez, Beatriz M. Illescas, Javier Rojo, Rafael Delgado, Nazario Martín
, 2021
, Pages 56-97
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 10 Repurposing Approved Drugs to Block Highly Pathogenic Emerging Viruses. B. Mercorelli, A. Loregian
, 2022
, Pages 232-255
- Carbon Nanostructures for Biomedical Applications, Subject Index
, 2021
, Pages 356-360